TA-65 Pharmacokinetic Study

NCT02731807 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DIETARY_SUPPLEMENT: Dose A: TA-65 24mg, powder
DIETARY_SUPPLEMENT: Dose B: TA-65, 8mg, powder
DIETARY_SUPPLEMENT: Dose C: TA-65 3.2mg, capsule
DIETARY_SUPPLEMENT: Dose D: TA-65 8mg, capsule
DIETARY_SUPPLEMENT: Dose E: TA-65 32mg, capsule

Sponsor

NYU Langone Health